Wei He
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
- Hepatology 37
- Hepatocellular Carcinoma Treatment and Prognosis 37
- Liver Disease and Transplantation 6
-
- MicroRNA in disease regulation 9
- Co-authors
- Yunfei Yuan (42 shared papers)Binkui Li (39 shared papers)Jiliang Qiu (36 shared papers)Denis C. Guttridge (3 shared papers)Yun Zheng (26 shared papers)Ruhai Zou (21 shared papers)Dinglan Zuo (18 shared papers)Priya Londhe (1 shared paper)
- Journals
- Journal of Cancer (4 papers)Cancer Communications (3 papers)Journal of Clinical Oncology (3 papers)Nature Communications (2 papers)Liver International (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei He
126 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 127
- Hepatology 606
- Cancer Research 797
- Oncology 558
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 526
Countries citing papers authored by Wei He
This map shows the geographic impact of Wei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei He more than expected).
Fields of papers citing papers by Wei He
This network shows the impact of papers produced by Wei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei He. The network helps show where Wei He may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 347 | |
| 2 | 2013 | 275 | |
| 3 | 2014 | 202 | |
| 4 | 2017 | 122 | |
| 5 | 2010 | 106 | |
| 6 | 2014 | 94 | |
| 7 | 2018 | 74 | |
| 8 | 2018 | 72 | |
| 9 | 2006 | 68 | |
| 10 | 2008 | 66 | |
| 11 | 2020 | 66 | |
| 12 | 2021 | 54 | |
| 13 | 2016 | 53 | |
| 14 | 2022 | 53 | |
| 15 | 2019 | 51 | |
| 16 | 2023 | 50 | |
| 17 | 2017 | 50 | |
| 18 | 2014 | 49 | |
| 19 | 2021 | 48 | |
| 20 | 2017 | 37 |
About Wei He
Wei He is a scholar working on Hepatology, Cancer Research, Hematology, Epidemiology and Health Informatics, having authored 134 papers that have together received 2.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Liver Disease Diagnosis and Treatment (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), RNA modifications and cancer (9 papers), Cancer Mechanisms and Therapy (9 papers), MicroRNA in disease regulation (9 papers), Liver Disease and Transplantation (6 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Hepatology (606 citations), Cancer Research (797 citations), Oncology (558 citations), Molecular Biology (1.3k citations) and Pulmonary and Respiratory Medicine (526 citations). Wei He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yunfei Yuan, Binkui Li, Jiliang Qiu, Denis C. Guttridge, Yun Zheng, Ruhai Zou, Dinglan Zuo, Priya Londhe, Alessandro Canella and Carlo M. Croce. Their work appears in journals such as Journal of Cancer, Cancer Communications, Journal of Clinical Oncology, Nature Communications and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.